Aprea Therapeutics
APRE
APRE
67 hedge funds and large institutions have $44.8M invested in Aprea Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $50.3M → $44.8M (-$5.47M)
22% less call options, than puts
Call options by funds: $201K | Put options by funds: $259K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
67
Holding in Top 10
1
Calls
$201K
Puts
$259K
Top Buyers
| 1 | +$3.23M | |
| 2 | +$2.68M | |
| 3 | +$1.59M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$1.55M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.02M |
Top Sellers
| 1 | -$6.21M | |
| 2 | -$3.87M | |
| 3 | -$2.93M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$2.55M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$906K |